SCHEMBL7467711

SCHEMBL7467711

CCCc1[nH]c2cc(C(=O)O)ccc2c1C(=O)C1CC1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.43
ALDH1A1 P00352 4/20 0.43
HPGD P15428 2/20 0.43
HSD17B10 Q99714 2/20 0.43
GAA P10253 1/20 0.43
PPARG P37231 1/20 0.42
PSMD14 O00487 1/20 0.42
RECQL P46063 1/20 0.42
RXFP1 Q9HBX9 1/20 0.42
TDP1 Q9NUW8 1/20 0.42
KMT2A Q03164 5/20 0.40
MEN1 O00255 2/20 0.40
PARP1 P09874 2/20 0.40
ATM Q13315 1/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
CCR3 P51677 1/20 0.39
DYRK1A Q13627 1/20 0.39
MPL P40238 2/20 0.39
ENPP2 Q13822 1/20 0.38
CYP1A2 P05177 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7471184 0.95 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7461131 0.95 KDM4E (0.41) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7425271 0.94 SRD5A2 (0.43) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7466167 0.89 GSK3B (0.43) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL7476488 0.87 KMT2A (0.57) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7422886 0.84 CHEK2 (0.46) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL7467838 0.84 CHEK2 (0.43) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL27483791 0.84 KDM4E (0.46) KDM4EALDH1A1HPGDHSD17B10GAA
SCHEMBL7417074 0.83 CHEK2 (0.47) KDM4EALDH1A1HSD17B10GAAKMT2A
SCHEMBL7423340 0.82 KMT2A (0.55) KDM4EALDH1A1HPGDHSD17B10GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
EP-0820441-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1998-01-28 EP disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed